GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.710
-0.040 (-1.45%)
At close: Dec 5, 2025, 4:00 PM EST
2.711
+0.001 (0.04%)
After-hours: Dec 5, 2025, 7:34 PM EST
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 5.48, with a low estimate of 4.00 and a high estimate of 7.00. The average target predicts an increase of 102.21% from the current stock price of 2.71.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GoodRx Holdings stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 2 | 2 |
| Buy | 6 | 4 | 4 | 4 | 4 | 3 |
| Hold | 4 | 4 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 9 | 9 | 9 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +84.50% | Nov 11, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +121.40% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $4.25 → $4 | Hold | Maintains | $4.25 → $4 | +47.60% | Nov 6, 2025 |
| Mizuho | Mizuho | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +47.60% | Nov 6, 2025 |
| UBS | UBS | Hold Maintains $5.25 → $4.25 | Hold | Maintains | $5.25 → $4.25 | +56.83% | Aug 11, 2025 |
Financial Forecast
Revenue This Year
810.57M
from 792.32M
Increased by 2.30%
Revenue Next Year
834.13M
from 810.57M
Increased by 2.91%
EPS This Year
0.37
from 0.04
Increased by 817.77%
EPS Next Year
0.45
from 0.37
Increased by 22.20%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 836.5M | 892.3M | ||||
| Avg | 810.6M | 834.1M | ||||
| Low | 777.1M | 773.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.6% | 10.1% | ||||
| Avg | 2.3% | 2.9% | ||||
| Low | -1.9% | -4.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.40 | 0.53 | |||
| Avg | 0.37 | 0.45 | |||
| Low | 0.33 | 0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 897.5% | 43.0% | |||
| Avg | 817.8% | 22.2% | |||
| Low | 733.0% | 4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.